| 中国体内放射性药物的现状与展望 |
| |
| 引用本文： | 刘伯里,金昱泰.中国体内放射性药物的现状与展望[J].核化学与放射化学,1989,11(4):229-235. |
| |
| 作者姓名： | 刘伯里 金昱泰 |
| |
| 作者单位： | 北京师范大学化学系
(刘伯里)，北京师范大学化学系(金昱泰) |
| |
| 摘 要： | 本文扼要介绍我国十年来体内放射性药物的进展。诊断和治疗用体内放射性药物的发展很迅速,已有反应堆生产与加速器生产的系列医用放射性核素及放射性药物,尤其是~(99m)Tc标记的脑、心灌注显像剂、放射免疫显像剂等。本文还对今后的发展提出一些建议与展望。
|
| 关 键 词： | 体内 放射性药物 现状 展望 |
PRESENT STATUS AND PROSPECT IN VIVO RADIOPHARMACEUTICALS IN CHINA |
| |
| LIU BOLI JIN YUTAI.PRESENT STATUS AND PROSPECT IN VIVO RADIOPHARMACEUTICALS IN CHINA[J].Journal of Nuclear and Radiochemistry,1989,11(4):229-235. |
| |
| Authors: | LIU BOLI JIN YUTAI |
| |
| Abstract: | The radiopharmaceutical chemistry is an important part in applied radio-chemistry. In this paper is given a review of in vivo radiopharmaceuticals in our country in recent years. It should be pointed out that in vivo radiopharmaceuticals including diagnostic and therapeutic have enjoyed rapid development. Recently, a series of reactor and cyclotron produced medical radionuclides and their radiopharmaceuticals, especially new 99mTc labelled brain perfusion imaging agents 99mTc-dl-HMPAO, 99mTc-ECD, myocardial perfusion imaging agents 99mTc-CPI and MIBI, radioimmunoimaging agents etc. have heen reported. Furthermore, R and D suggestions and future trends are discussed. |
| |
| Keywords: | In vivo radiopharmaceuticals Diagnostic and therapeutic radiopharmaceuticals Perfusion imaging agent Radioimmunoimaging agent |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
